Werfel Asked To Clarify How To Treat R&D Costs In M&A

By Law360 Staff

Accounting firm RSM US LLP, in a letter released Tuesday, asked Internal Revenue Commissioner Daniel Werfel to clarify how to treat research and development costs when a taxpayer disposes of an entire business in a mergers and acquisitions transaction.

 Letter attached | Read full article » | Save to favorites »